- Home
- Publications
- Publication Search
- Publication Details
Title
Novel therapeutic options for cachexia and sarcopenia
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 16, Issue 10, Pages 1239-1244
Publisher
Informa UK Limited
Online
2016-07-06
DOI
10.1080/14712598.2016.1208168
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting cancer cachexia: we're on the way
- (2016) Maurizio Muscaritoli LANCET ONCOLOGY
- Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials
- (2016) Jennifer S Temel et al. LANCET ONCOLOGY
- Lipolytic and thermogenic depletion of adipose tissue in cancer cachexia
- (2016) Maria Tsoli et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohn's disease
- (2015) K. Subramaniam et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Frailty, Exercise and Nutrition
- (2015) Jean-Pierre Michel et al. CLINICS IN GERIATRIC MEDICINE
- Cachexia: A preventable comorbidity of cancer. A T.A.R.G.E.T. approach
- (2015) Maurizio Muscaritoli et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Enobosarm (GTx-024) Modulates Adult Skeletal Muscle Mass Independently of the Androgen Receptor in the Satellite Cell Lineage
- (2015) Vanessa Dubois et al. ENDOCRINOLOGY
- The role of microRNAs in skeletal muscle health and disease
- (2015) John J. McCarthy Frontiers in Bioscience-Landmark
- Treatment of cachexia: An overview of recent developments
- (2015) Stephan von Haehling et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Carnitine for the treatment of cachexia: Lights and shadows
- (2015) Alessio Molfino et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials
- (2015) José M Garcia et al. LANCET ONCOLOGY
- Skeletal muscle atrophy: Potential therapeutic agents and their mechanisms of action
- (2015) Vikas Dutt et al. PHARMACOLOGICAL RESEARCH
- Request for regulatory guidance for cancer cachexia intervention trials
- (2015) KCH Fearon et al. Journal of Cachexia Sarcopenia and Muscle
- Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment
- (2015) Cathleen Drescher et al. Journal of Cachexia Sarcopenia and Muscle
- Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial
- (2015) Clemens Becker et al. Lancet Diabetes & Endocrinology
- Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: From sarcopenic obesity to cachexia
- (2014) Gianni Biolo et al. CLINICAL NUTRITION
- Ghrelin
- (2014) Alessio Molfino et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Multimodal nutrition/anabolic therapy for wasting conditions
- (2014) Trude Rakel Balstad et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- MECHANISMS IN ENDOCRINOLOGY: Regulation of glucose metabolism by the ghrelin system: multiple players and multiple actions
- (2014) Kristy M Heppner et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Cancer cachexia: towards integrated therapeutic interventions
- (2014) Alessio Molfino et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Enobosarm (GTx-024, S-22): a potential treatment for cachexia
- (2014) Reshmi Srinath et al. Future Oncology
- Validating the SARC-F: A Suitable Community Screening Tool for Sarcopenia?
- (2014) Jean Woo et al. Journal of the American Medical Directors Association
- MicroRNAs as potential biomarkers in diseases and toxicology
- (2014) Bénazir Siddeek et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- Treatment of sporadic inclusion body myositis with bimagrumab
- (2014) A. A. Amato et al. NEUROLOGY
- Tocilizumab, a Proposed Therapy for the Cachexia of Interleukin6-Expressing Lung Cancer
- (2014) Katsutoshi Ando et al. PLoS One
- Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7
- (2014) W. A. He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile
- (2014) Claudio Pietra et al. Journal of Cachexia Sarcopenia and Muscle
- Sarcopenia: describing rather than defining a condition
- (2014) David Rhys Alchin Journal of Cachexia Sarcopenia and Muscle
- The hunger hormone ghrelin in cachexia
- (2013) Alessio Molfino et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Myostatin/activin pathway antagonism: Molecular basis and therapeutic potential
- (2013) H.Q. Han et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
- (2013) Lisa Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial
- (2013) Adrian S Dobs et al. LANCET ONCOLOGY
- Mechanism and novel therapeutic approaches to wasting in chronic disease
- (2013) Nicole Ebner et al. MATURITAS
- An Antibody Blocking Activin Type II Receptors Induces Strong Skeletal Muscle Hypertrophy and Protects from Atrophy
- (2013) E. Lach-Trifilieff et al. MOLECULAR AND CELLULAR BIOLOGY
- Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
- (2013) Xin Yao et al. PHARMACOLOGY & THERAPEUTICS
- Relationship between muscle mass and muscle strength, and the impact of comorbidities: a population-based, cross-sectional study of older adults in the United States
- (2013) Lei Chen et al. BMC Geriatrics
- Current pharmacotherapy options for cancer anorexia and cachexia
- (2012) Antonio Macciò et al. EXPERT OPINION ON PHARMACOTHERAPY
- Muscle atrophy in aging and chronic diseases: is it sarcopenia or cachexia?
- (2012) Maurizio Muscaritoli et al. Internal and Emergency Medicine
- Therapeutic potential of ghrelin treatment for unloading-induced muscle atrophy in mice
- (2011) Keiichi Koshinaka et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions
- (2011) Vanessa Dubois et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- The role of myostatin in muscle wasting: an overview
- (2011) Yulia Elkina et al. Journal of Cachexia Sarcopenia and Muscle
- Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
- (2010) Xiaolan Zhou et al. CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now